HOME >> BIOLOGY >> NEWS
AAAS CEO Alan I. Leshner statement on the UN cloning debate

Washington, DC -- A statement from Dr. Alan I. Leshner, CEO of the American Association for the Advancement of Science and executive publisher of the journal Science, on the debate over research cloning that is scheduled to begin at the United Nations on Thursday 21 October 2004:

"We realize that this issue generates intense debate. We have long opposed human cloning to produce babies as dangerous and irresponsible. But we believe that nuclear cell transplantation research - what is called research or therapeutic cloning - holds the potential to ease tremendous suffering and prolong life for countless millions of people. For that reason, this window of scientific and eventual clinical opportunity should not be shut prematurely.

"These positions are reflected in the measure sponsored by Belgium-a measure that clearly represents the mainstream of scientific and medical thinking in the United States and worldwide."


'"/>

Contact: Ginger Pinholster
gpinhols@aaas.org
202-326-6421
American Association for the Advancement of Science
20-Oct-2004


Page: 1

Related biology news :

1. Statement from Dr. Alan I. Leshner, CEO of AAAS, on the Kansas State Board of Education vote
2. AAAS CEO Alan I. Leshner urges US to continue collecting job data on women workers
3. AAAS CEO Alan I. Leshner registers strong concerns over suppression of science films
4. AAAS CEO Alan I. Leshner welcomes proposed Washington state legislation on stem cell research
5. Science academies issue statements on energy efficiency, innovation
6. AAAS releases video and first board consensus statement on climate change
7. Draft environmental impact statement prepared for USAMRIID facilities at Fort Detrick
8. Environmental impact statement planned for USAMRIID facilities at Fort Detrick
9. The AIUM releases new statement regarding keepsake imaging
10. AGU statement on future of Earth and space science research at NASA
11. Amgens decision to block reinstatement of GDNF is faulted by a leading Parkinsons advocacy group

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/29/2018)... (PRWEB) , ... August 29, ... ... study validates first non-invasive technology to identify specific chromosomal abnormalities using morphological ... Ovation Fertility and Australia-based Life Whisperer suggests that ...
(Date:8/26/2018)... ... August 24, 2018 , ... ... laboratories. However, this technology introduces many well-described challenges around data processing, storage ... South London NHS Genomic Medicine Centre. The Viapath Genetics Laboratories have implemented ...
(Date:8/23/2018)... ... ... Mandy is an eight-year-old mini Australian shepherd and a tripod. When Mandy was four years ... surgeries to try to repair the leg and each time it was unsuccessful. Once ... along with her veterinarian, decided to amputate. With only one front leg, mobility in ...
Breaking Biology News(10 mins):
(Date:9/13/2018)... ... ... Asymmetrex’s director, James L. Sherley, M.D., Ph.D., asks audiences questions like, “How ... the means to measure the number of drug molecules in drug development research or ... holding up progress in stem cell medicine.” , “Can you imagine taking an approved ...
(Date:9/12/2018)... ... September 12, 2018 , ... NDA Partners Chairman Carl ... Senior Director of Regulatory Affairs and Quality Systems at WellDoc, Inc., has joined ... Affairs and Quality Systems at WellDoc, Inc., she conducted quality control and supplier ...
(Date:9/7/2018)... ... September 06, 2018 , ... ... disease, has been validated to be as effective as manual pathology. The study, ... in Frozen Muscle Biopsies,” was published in the Archives of Pathology & Laboratory ...
(Date:8/31/2018)... ... August 30, 2018 , ... Small, wireless and networked describes ... down and getting connected, too. Draper’s latest system is tiny in size, but is ... A driving factor in the new implant design is the growing awareness that disease ...
Breaking Biology Technology:
Cached News: